TG Therapeutics | TGTX - EPS Earnings Per Share


TG Therapeutics reported $0.12 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 0.40 2.43 Nov/09
FY2026Q2 Jun/2026 0.33 0.17 Aug/10
FY2026Q1 Mar/2026 0.12 0.28 0.03 May/06
FY2025Q4 Dec/2025 0.14 0.33 0.15 Feb/26
FY2025Q3 Sep/2025 2.43 0.25 0.02 Nov/03




Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Alaunos Therapeutics USD -0.52 0.02 Mar/2026
Amgen USD 5.15 0.14 Mar/2026
Ardelyx USD -0.15 0.15 Mar/2026
Arrowhead Research USD -0.93 1.15 Mar/2026
Bayer EUR 2.71 2.09 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
Corcept Therapeutics USD -0.3 0.5 Mar/2026
Curis USD 1.23 3.26 Dec/2025
Gilead Sciences USD 2.03 0.17 Mar/2026
J&J USD 2.9 0.2 Jun/2026
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
Novartis USD 1.99 0.04 Mar/2026
Novavax USD 0.13 0.59 Dec/2025
PTC Therapeutics USD -0.03 1.64 Mar/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
TG Therapeutics USD 0.12 0.02 Mar/2026
Verastem USD -0.48 0.12 Dec/2025
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026